Medacta Group SA
SIX:MOVE

Watchlist Manager
Medacta Group SA Logo
Medacta Group SA
SIX:MOVE
Watchlist
Price: 131.6 CHF -0.45% Market Closed
Market Cap: 2.6B CHF
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+15%
Revenue
Forecast
+6%
Operating Income
Forecast
+18%
Net Income
Forecast
+41%

Wall Street
Price Targets

MOVE Price Targets Summary
Medacta Group SA

Wall Street analysts forecast MOVE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOVE is 151.16 CHF with a low forecast of 137.36 CHF and a high forecast of 168 CHF.

MOVE Lowest Forecast
Wall Street Target
137.36 CHF
4% Upside
MOVE Average Forecast
Wall Street Target
151.16 CHF
15% Upside
MOVE Highest Forecast
Wall Street Target
168 CHF
28% Upside
Lowest
Price Target
137.36 CHF
4% Upside
Average
Price Target
151.16 CHF
15% Upside
Highest
Price Target
168 CHF
28% Upside
Medacta Group SA Competitors:
Price Targets
SOON
Sonova Holding AG
18% Upside
M
MYO
Myomo Inc
89% Upside
W
336570
Won Tech Co Ltd
9% Upside
SEQUA
Sequana Medical NV
339% Upside
SOON
Sonova Holding AG
18% Upside
M
MYO
Myomo Inc
89% Upside
W
336570
Won Tech Co Ltd
9% Upside
SEQUA
Sequana Medical NV
339% Upside
HOLX
Hologic Inc
30% Upside
J
002223
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
33% Upside
COH
Cochlear Ltd
12% Upside
EMBLA
Embla Medical hf
47% Upside

Revenue
Forecast

Revenue Estimate
Medacta Group SA

For the last 6 years the compound annual growth rate for Medacta Group SA's revenue is 13%. The projected CAGR for the next 4 years is 16%.

13%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Medacta Group SA

For the last 6 years the compound annual growth rate for Medacta Group SA's operating income is 7%. The projected CAGR for the next 4 years is 17%.

7%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Medacta Group SA

For the last 6 years the compound annual growth rate for Medacta Group SA's net income is 6%. The projected CAGR for the next 3 years is 29%.

6%
Past Growth
29%
Estimated Growth
Estimates Accuracy
-22%
Average Miss
What are analyst estimates?

See Also

Summary
MOVE intrinsic value, competitors valuation, and company profile.
DCF Valuation
MOVE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MOVE stock valuation using valuation multiples.
Wall Street Estimates
MOVE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MOVE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOVE's stock price target?
Price Target
151.16 CHF

According to Wall Street analysts, the average 1-year price target for MOVE is 151.16 CHF with a low forecast of 137.36 CHF and a high forecast of 168 CHF.

What is Medacta Group SA's Revenue forecast?
Projected CAGR
16%

For the last 6 years the compound annual growth rate for Medacta Group SA's revenue is 13%. The projected CAGR for the next 4 years is 16%.

What is Medacta Group SA's Operating Income forecast?
Projected CAGR
17%

For the last 6 years the compound annual growth rate for Medacta Group SA's operating income is 7%. The projected CAGR for the next 4 years is 17%.

What is Medacta Group SA's Net Income forecast?
Projected CAGR
29%

For the last 6 years the compound annual growth rate for Medacta Group SA's net income is 6%. The projected CAGR for the next 3 years is 29%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 241,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.